Streetbeat News

Stock Prices

EL

Analysts have provided various ratings for Estee Lauder Cos (NYSE:EL) within the last quarter, with a majority leaning towards bullish. The average 12-month price target for Estee Lauder Cos, according to 20 analysts, is $252.2, a decrease of 11.82% from the previous average price target of $286.00.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 8:01 pm

SAM

In the last quarter, Boston Beer Co (NYSE:SAM) received 1 bullish, 3 indifferent, and 1 somewhat bearish rating from analysts. The company's average 12-month price target is $326.2, a 10.7% increase from the previous average of $294.67.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 8:01 pm

STM

STMicroelectronics's (NYSE:STM) short percent of float has fallen 29.52% since its last report, with 6.70 million shares sold short, which is 0.74% of all regular shares available for trading. This decrease in short interest could signal a more bullish sentiment towards the stock. Compared to its peers, STMicroelectronics has less short interest.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 8:01 pm

OLN

Over the last quarter, Olin (NYSE:OLN) has received mostly somewhat bullish ratings from analysts, with 6 out of 8 analysts giving this rating. The company has an average price target of $63.62, representing a 12.16% decrease from the previous average price target of $72.43.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 8:01 pm

MET

MetLife's (NYSE:MET) short percent of float has risen 3.66% since its last report, with 10.93 million shares sold short, which is 1.7% of all regular shares available for trading. It would take traders 2.08 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. MetLife's peer group average for short interest as a percentage of float is 3.47%, which means the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 8:00 pm

REGN

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 15 years by 19.64% on an annualized basis, producing an average annual return of 28.49%. If an investor had bought $100 of REGN stock 15 years ago, it would be worth $4,613.39 today.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 8:00 pm

NU

The short percent of float for Nu Holdings (NYSE:NU) has decreased by 15.77% since its last report, with 65.80 million shares sold short, representing 2.19% of all regular shares available for trading. This decrease in short interest could indicate a more bullish market sentiment towards the stock. However, compared to its peers, Nu Holdings has a higher short interest as a percentage of float, which is 0.90% on average.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 8:00 pm

BRDG

Bridge Investment Group (NYSE:BRDG) has received four somewhat bullish ratings and one indifferent rating from analysts in the last quarter. The average 12-month price target for the company is $14.5, a decrease of 14.71% from the previous average price target of $17.00.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 8:00 pm

CAT

Caterpillar (NYSE:CAT) has outperformed the market over the past 20 years, producing an average annual return of 10.75%. If an investor had bought $100 of CAT stock 20 years ago, it would be worth $796.08 today. The company currently has a market capitalization of $130.36 billion.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 8:00 pm

CHK

Over the past 3 months, 8 analysts have published their opinion on Chesapeake Energy (NASDAQ:CHK) stock. The average price target for the stock has increased by 11.74% from the previous average price target of $81.33 to $90.88. The majority of the analysts are indifferent about the stock with 6 out of 8 giving a neutral rating.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 8:00 pm